NASDAQ
Bellerophon Therapeutics, Inc. (BLPH) has a fcf yield of -206.73% as of Friday, May 29, 2026. This represents a 313.17% decrease compared to its 12-month average of -50.04%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.